Cargando…

Endotoxaemia in Haemodialysis: A Novel Factor in Erythropoetin Resistance?

BACKGROUND/OBJECTIVES: Translocated endotoxin derived from intestinal bacteria is a driver of systemic inflammation and oxidative stress. Severe endotoxaemia is an underappreciated, but characteristic finding in haemodialysis (HD) patients, and appears to be driven by acute repetitive dialysis induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Laura E. A., Burton, James O., Szeto, Cheuk-Chun, Li, Philip K. T., McIntyre, Christopher W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387022/
https://www.ncbi.nlm.nih.gov/pubmed/22768256
http://dx.doi.org/10.1371/journal.pone.0040209
_version_ 1782237056154468352
author Harrison, Laura E. A.
Burton, James O.
Szeto, Cheuk-Chun
Li, Philip K. T.
McIntyre, Christopher W.
author_facet Harrison, Laura E. A.
Burton, James O.
Szeto, Cheuk-Chun
Li, Philip K. T.
McIntyre, Christopher W.
author_sort Harrison, Laura E. A.
collection PubMed
description BACKGROUND/OBJECTIVES: Translocated endotoxin derived from intestinal bacteria is a driver of systemic inflammation and oxidative stress. Severe endotoxaemia is an underappreciated, but characteristic finding in haemodialysis (HD) patients, and appears to be driven by acute repetitive dialysis induced circulatory stress. Resistance to erythropoietin (EPO) has been identified as a predictor of mortality risk, and associated with inflammation and malnutrition. This study aims to explore the potential link between previously unrecognised endotoxaemia and EPO Resistance Index (ERI) in HD patients. METHODOLOGY/PRINCIPAL FINDINGS: 50 established HD patients were studied at a routine dialysis session. Data collection included weight, BMI, ultrafiltration volume, weekly EPO dose, and blood sampling pre and post HD. ERI was calculated as ratio of total weekly EPO dose to body weight (U/kg) to haemoglobin level (g/dL). Mean haemoglobin (Hb) was 11.3±1.3 g/dL with a median EPO dose of 10,000 [IQR 7,500–20,000] u/wk and ERI of 13.7 [IQR 6.9–23.3] ((U/Kg)/(g/dL)). Mean pre-HD serum ET levels were significantly elevated at 0.69±0.30 EU/ml. Natural logarithm (Ln) of ERI correlated to predialysis ET levels (r = 0.324, p = 0.03) with a trend towards association with hsCRP (r = 0.280, p = 0.07). Ln ERI correlated with ultrafiltration volume, a driver of circulatory stress (r = 0.295, p = 0.046), previously identified to be associated with increased intradialytic endotoxin translocation. Both serum ET and ultrafiltration volume corrected for body weight were independently associated with Ln ERI in multivariable analysis. CONCLUSIONS: This study suggests that endotoxaemia is a significant factor in setting levels of EPO requirement. It raises the possibility that elevated EPO doses may in part merely be identifying patients subjected to significant circulatory stress and suffering the myriad of negative biological consequences arising from sustained systemic exposure to endotoxin.
format Online
Article
Text
id pubmed-3387022
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33870222012-07-05 Endotoxaemia in Haemodialysis: A Novel Factor in Erythropoetin Resistance? Harrison, Laura E. A. Burton, James O. Szeto, Cheuk-Chun Li, Philip K. T. McIntyre, Christopher W. PLoS One Research Article BACKGROUND/OBJECTIVES: Translocated endotoxin derived from intestinal bacteria is a driver of systemic inflammation and oxidative stress. Severe endotoxaemia is an underappreciated, but characteristic finding in haemodialysis (HD) patients, and appears to be driven by acute repetitive dialysis induced circulatory stress. Resistance to erythropoietin (EPO) has been identified as a predictor of mortality risk, and associated with inflammation and malnutrition. This study aims to explore the potential link between previously unrecognised endotoxaemia and EPO Resistance Index (ERI) in HD patients. METHODOLOGY/PRINCIPAL FINDINGS: 50 established HD patients were studied at a routine dialysis session. Data collection included weight, BMI, ultrafiltration volume, weekly EPO dose, and blood sampling pre and post HD. ERI was calculated as ratio of total weekly EPO dose to body weight (U/kg) to haemoglobin level (g/dL). Mean haemoglobin (Hb) was 11.3±1.3 g/dL with a median EPO dose of 10,000 [IQR 7,500–20,000] u/wk and ERI of 13.7 [IQR 6.9–23.3] ((U/Kg)/(g/dL)). Mean pre-HD serum ET levels were significantly elevated at 0.69±0.30 EU/ml. Natural logarithm (Ln) of ERI correlated to predialysis ET levels (r = 0.324, p = 0.03) with a trend towards association with hsCRP (r = 0.280, p = 0.07). Ln ERI correlated with ultrafiltration volume, a driver of circulatory stress (r = 0.295, p = 0.046), previously identified to be associated with increased intradialytic endotoxin translocation. Both serum ET and ultrafiltration volume corrected for body weight were independently associated with Ln ERI in multivariable analysis. CONCLUSIONS: This study suggests that endotoxaemia is a significant factor in setting levels of EPO requirement. It raises the possibility that elevated EPO doses may in part merely be identifying patients subjected to significant circulatory stress and suffering the myriad of negative biological consequences arising from sustained systemic exposure to endotoxin. Public Library of Science 2012-06-29 /pmc/articles/PMC3387022/ /pubmed/22768256 http://dx.doi.org/10.1371/journal.pone.0040209 Text en Harrison et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Harrison, Laura E. A.
Burton, James O.
Szeto, Cheuk-Chun
Li, Philip K. T.
McIntyre, Christopher W.
Endotoxaemia in Haemodialysis: A Novel Factor in Erythropoetin Resistance?
title Endotoxaemia in Haemodialysis: A Novel Factor in Erythropoetin Resistance?
title_full Endotoxaemia in Haemodialysis: A Novel Factor in Erythropoetin Resistance?
title_fullStr Endotoxaemia in Haemodialysis: A Novel Factor in Erythropoetin Resistance?
title_full_unstemmed Endotoxaemia in Haemodialysis: A Novel Factor in Erythropoetin Resistance?
title_short Endotoxaemia in Haemodialysis: A Novel Factor in Erythropoetin Resistance?
title_sort endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387022/
https://www.ncbi.nlm.nih.gov/pubmed/22768256
http://dx.doi.org/10.1371/journal.pone.0040209
work_keys_str_mv AT harrisonlauraea endotoxaemiainhaemodialysisanovelfactorinerythropoetinresistance
AT burtonjameso endotoxaemiainhaemodialysisanovelfactorinerythropoetinresistance
AT szetocheukchun endotoxaemiainhaemodialysisanovelfactorinerythropoetinresistance
AT liphilipkt endotoxaemiainhaemodialysisanovelfactorinerythropoetinresistance
AT mcintyrechristopherw endotoxaemiainhaemodialysisanovelfactorinerythropoetinresistance